![PDF) Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVMIa melanoma: Subanalysis of the phase III OPTiM trial PDF) Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVMIa melanoma: Subanalysis of the phase III OPTiM trial](https://i1.rgstatic.net/publication/310491060_Efficacy_and_safety_of_talimogene_laherparepvec_versus_granulocyte-macrophage_colony-stimulating_factor_in_patients_with_stage_IIIBC_and_IVMIa_melanoma_Subanalysis_of_the_phase_III_OPTiM_trial/links/5830079108aef19cb8164e9e/largepreview.png)
PDF) Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVMIa melanoma: Subanalysis of the phase III OPTiM trial
![PDF) 421 Initial results of a phase 1 trial of RP2, a first in class, enhanced potency, anti-CTLA-4 antibody expressing, oncolytic HSV as single agent and combined with nivolumab in patients with PDF) 421 Initial results of a phase 1 trial of RP2, a first in class, enhanced potency, anti-CTLA-4 antibody expressing, oncolytic HSV as single agent and combined with nivolumab in patients with](https://i1.rgstatic.net/publication/346801208_421_Initial_results_of_a_phase_1_trial_of_RP2_a_first_in_class_enhanced_potency_anti-CTLA-4_antibody_expressing_oncolytic_HSV_as_single_agent_and_combined_with_nivolumab_in_patients_with_solid_tumors/links/60e2d7f9299bf1ea9ee131a6/largepreview.png)
PDF) 421 Initial results of a phase 1 trial of RP2, a first in class, enhanced potency, anti-CTLA-4 antibody expressing, oncolytic HSV as single agent and combined with nivolumab in patients with
![In letter to Maine Med, Democratic lawmakers call out hospital for attempted union busting – Maine Beacon In letter to Maine Med, Democratic lawmakers call out hospital for attempted union busting – Maine Beacon](https://mainebeacon.com/wp-content/uploads/2021/01/maine-medical-center-916x524.jpg)